AMA Shares OTC Birth Control Diagnosis With FDA

American College of Obstetricians and Gynecologists proposed amending existing AMA policy in anticipation of Perrigo’s HRA business submitting NDA to FDA for OTC switch of progestin-only daily oral contraceptive the end of 2022.

• Source: Shutterstock

The American Medical Association for the first time is encouraging the Food and Drug Administration to make daily oral contraceptives available OTC after previously targeting its suggestion for manufacturers.

The recommendation was announced following a vote during the meeting of the association’s policy-making body on a proposal submitted by...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Rx-to-OTC Switch

More from Health